MC2 Therapeutics

MC2 Therapeutics is a commercial stage biotech company focused on developing novel treatment paradigms within immune-mediated and inflammatory conditions. Our innovative approach to address complex challenges more effectively is anchored in deep understanding of the skin biology and this knowledge can be leveraged to inform approaches in other disease segments in the immune-mediated and inflammatory field. Fuelled by an entrepreneurial mindset and creativity, MC2 Therapeutics aims to set new standards in treatment satisfaction for people with immune-mediated and inflammatory skin conditions. This page is not intended for discussions about products. As such, postings or comments that contain product discussions may...

Skin biology ,pharmaceuticals,and immune-mediated inflammatory diseases

Mc2 therapeutics operates in the Pharmaceutical manufacturing industry.

Mc2 therapeutics's revenue is 11m - 100m

Mc2 therapeutics has 11 - 50 employees.